Biotechnology firm LianBio raised $325 million in an initial public offering, according to a statement, potentially opening a narrow path for U.S. listings by companies operating primarily in …
( read original story …)
The Shanghai News
Biotechnology firm LianBio raised $325 million in an initial public offering, according to a statement, potentially opening a narrow path for U.S. listings by companies operating primarily in …
( read original story …)